Business Context and Reporting Period
This Form 6-K filing by AMBEV S.A. covers the month of January 2017, with the report signed on January 10, 2017. The document serves as a report of foreign private issuer transactions pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934. The content specifically details consolidated transactions of securities and derivatives by the company's Management, Board of Directors, and Fiscal Council in compliance with Article 11 of CVM Instruction # 358/2002.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a disclosure of insider trading activity and does not contain consolidated financial statements or operational metrics.
Insider trading activity reported for December 2016 (disclosed in this January 2017 filing) includes:
- Management Group:
- Initial Balance: 5,069,436 Common Shares (0.0323%) and 1,195,100 ADRs (0.0076%).
- Transactions: Net purchase of 43,100 shares (46,000 bought via options exercise; 2,900 sold).
- Final Balance: 5,112,536 Common Shares (0.0325%) and 1,195,100 ADRs (0.0076%).
- Board of Directors Group:
- Initial Balance: 26,529,315 Common Shares (0.1688%) and 619,333 ADRs (0.0039%).
- Transactions: No transactions reported.
- Final Balance: 26,529,315 Common Shares (0.1688%) and 619,333 ADRs (0.0039%).
- Fiscal Council Group:
- Initial Balance: 7,225 Common Shares (0.0000%).
- Transactions: No transactions reported.
- Final Balance: 7,225 Common Shares (0.0000%).
Material Changes
The only material change reported is the increase in the Management group's shareholding due to the exercise of options. The Board of Directors and Fiscal Council maintained static positions during the reporting period. No changes in the company's overall capital structure or financial performance are disclosed in this text.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary on operations, risks, contingencies, or unusual items. The document is limited to the statutory reporting of securities transactions by related persons.
Investor Verification Checklist
- Verify the specific identities of the management personnel who exercised options and sold shares in December 2016.
- Confirm the exercise price of the options (R$ 3.57096) versus the market price at the time of sale (approx. R$ 16.20 - R$ 16.43).
- Review the full CVM Instruction # 358/2002 compliance report for any omitted details regarding related party transactions.
- Check subsequent filings for the company's actual Q4 2016 and Q1 2017 financial results, as they are not included here.